New Stem Cell Therapy To Help With Stubborn Wounds PDF Print E-mail
Friday, 26 August 2011 12:13
The skin is the largest organ in the body with amazing healing powers, but what if your wounds didn't heal?

That's the case for 6 million Americans suffering from chronic wounds that can take months, even years, to heal. Millions have no other choice besides amputation; but now, a new stem cell therapy is helping to change that.

Limited scleroderma or CREST syndrome, is a subtype of Scleroderma, a condition that means "hardened skin." Skin changes associated with CREST syndrome typically occur in the lower arms and legs and sometimes in the face and throat. CREST syndrome can also affect the digestive tract and can cause serious heart and lung disorders. There is no known cure for Scleroderma, but treatments focus on managing symptoms and preventing serious complications. Sometimes, patients with this syndrome have a difficult time healing.

Doctors at the University of Miami Miller School of Medicine are participating in a study that takes stem cells from a patient's own body and uses them to treat their stubborn wounds. Adult stem cells are becoming a more realistic option for treating wounds that are refusing to heal. Certain stem cells can be isolated from bone marrow and other tissues, such as adipose and skin tissue.

Rapid regeneration of skin can be achieved after the transplantation of these cells. Stem cells can be obtained not only from the outside of the skin but also from local skin. Cell therapy is the transplantation of allogeneic cells to restore viability and function of deficient tissues.

Some scholars believe that the plasticity of stem cells is a result of the cell fusion between adult stem cells and skin cells. Therefore, it is important to create an appropriate microenvironment, which will be the determining factor as to whether or not stem cells will survive and participate in regeneration and reparation of wounds.

Researchers are already planning the next trial to test the use of donor bone marrow stem cells on the chronic wounds of patients whose own stem cells are likely compromised.

To learn more about this research, contact head of Media Relations with the University of Miami Miller School of Medicine Omar Montejo at (305) 243-5654 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Source: McFadden, M. (2011), "Healing wounds with your own stem cells", Gray Television Interactive, WNDU.com

 
More articles :

» Rare T Follicular Helper Cells Could Hold Key To Treating Immune Disorders

The characterization of a rare immune cell’s involvement in antibody production and ability to ‘remember’ infectious agents could help to improve vaccination and lead to new treatments for immune disorders, say researchers from the .The cells,...

» Digital Ulcers Linked to More Severe Systemic Sclerosis

Digital ulcers are associated with more severe systemic sclerosis (SSc) disease, including skin and lung involvement, but not with pulmonary arterial hypertension (PAH) or scleroderma renal crisis (SRC), according to research published in the...

» Researchers Gain Deeper Insights Into Causes And New Treatment Strategies For Scleroderma

Using mice, lab-grown cells and clues from a related disorder, Johns Hopkins researchers have greatly increased understanding of the causes of , showing that a critical culprit is a defect in the way certain cells communicate with their structural...

» UTHealth, Fudan University Launch Scleroderma Network

Scleroderma clinicians and researchers in the United States and China have launched an international network to fight this debilitating disease that affects more than one million people worldwide.The network was established by faculty at The...

» Development of an Activity Index for Localized Scleroderma (Morphea)

E. Lanciano, A. CHIALà, E. Praino, V. Grattagliano, M. Covelli, F. Iannone, G. Lapadula Reumatologia Universitaria, Policlinico, Bari, ItalyAnn Rheum Dis 2011;70(Suppl3):481Background: Morphea is a skin disorder characterized by fibrosis. It...

» Scleroderma-Related PAH: The Need for Early Diagnosis and Treatment

Pulmonary arterial hypertension (PAH) associated with scleroderma (systemic sclerosis) is an aggressive disorder with a poor prognosis. Effective therapies are available for PAH but patients with scleroderma-associated PAH have a poorer response to...